Has Daniel Feldman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,628 in general payments to Daniel Feldman, MD across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Feldman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Feldman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Feldman, MD

Interventional Pain Medicine · Farmington Hills, MINPI 1649562307

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 36.7% of the total. Reporting peaked in 2019 at $557 and has fallen 78.1% since, to $122 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MI, where the typical reported total is $2,071.

$1,628in general payments, 2019–2025

Across 85 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$597
Edwards Lifesciences$205
Axsome Therapeutics, Inc.$122
Assertio Therapeutics, Inc.$121
Lilly USA, LLC$103
Boston Scientific$82
plus $397 from 12 others

What the payments were for

Food & beverage$1,628100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	30	$597
Edwards Lifesciences	2	$205
Axsome Therapeutics, Inc.	1	$122
Assertio Therapeutics, Inc.	25	$121
Lilly USA, LLC	1	$103
Boston Scientific	4	$82
Lundbeck LLC	2	$51
Siemens Medical Solutions USA, Inc.	2	$50
Teva Pharmaceuticals USA, Inc.	4	$47
Genentech USA, Inc.	2	$42
UCB, Inc.	2	$37
Amgen	2	$36
Medtronic	2	$31
Pacira Pharmaceuticals Incorporated	2	$27
Biohaven Pharmaceutical Holding Company Ltd.	1	$20
Nalu Medical, Inc.	1	$20
Johnson & Johnson	1	$19
SK Life Science, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$166
Symbravo$122
BOTOX COSMETIC$102

How this compares

$1,628 in reported general payments places this provider in the 45th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan →

Medicare billing

Part B allowed, 2024

$223,984

Medicare patients

196

Services billed

5,573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	41	$803
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	66	$570
Nortriptyline Hcl	17	$243
Topiramate	19	$236
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	13	$204
Amitriptyline Hcl	12	$106
Cyclobenzaprine Hcl	16	$83
Diazepam	35	$24

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Farmington Hills

Fawad RizviFarmington Hills$16K
Dennis DobrittFarmington Hills$3K
Sean ConroyFarmington Hills$2K
Ryan PollinaSaint Clair Shores$144K
Ariel MajjhooMonroe$124K
Chad BrummettAnn Arbor$109K
Anand ThakurClinton Township$102K
Evan PeskinFlint$72K
Richard FerroLansing$31K
John ChatasAnn Arbor$29K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →